Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/20.500.14279/9306
Τίτλος: | Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer | Συγγραφείς: | Kalogera, Eleni Pistos, Constantinos M. Provatopoulou, Xeni Christophi, Costas A. Zografos, George Constantine Stefanidou, Maria E. Spiliopoulou, Chara A. Athanaselis, Sotiris A. Gounaris, Antonia D. |
Major Field of Science: | Medical and Health Sciences | Field Category: | Health Sciences | Λέξεις-κλειδιά: | Breast cancer;Plasma androgens;Androgen glucuronides | Ημερομηνία Έκδοσης: | 1-Απρ-2016 | Πηγή: | Journal of Chromatographic Science, 2016, vol. 54, no.4, pp. 583-592 | Volume: | 54 | Issue: | 4 | Start page: | 583 | End page: | 592 | Περιοδικό: | Journal of Chromatographic Science | Περίληψη: | The physiological and pathological development of the breast is strongly affected by the hormonal milieu consisting of steroid hormones. Mass spectrometry (MS) technologies of high sensitivity and specificity enable the quantification of androgens and consequently the characterization of the hormonal status. The aim of this study is the assessment of plasma androgens and androgen glucuronides, in the par excellence hormone-sensitive tissue of the breast, through the application of liquid chromatography-mass spectrometry (LC-MS). A simple and efficient fit-for-purpose method for the simultaneous identification and quantification of dehydroepiandrosterone sulfate (DHEAS), androstenedione (A4), androsterone glucuronide (ADTG) and androstane-3α, 17β-diol-17-glucuronide (3α-diol-17G) in human plasma was developed and validated. The presented method permits omission of derivatization, requires a single solid-phase extraction procedure and the chromatographic separation can be achieved on a single C18 analytical column, for all four analytes. The validated method was successfully applied for the analysis of 191 human plasma samples from postmenopausal women with benign breast disease (BBD), lobular neoplasia (LN), ductal carcinoma in situ and invasive ductal carcinoma (IDC). DHEAS plasma levels exhibited significant differences between LN, IDC and BBD patients (P < 0.05). Additionally, ADTG levels were significantly higher in patients with LN compared with those with BBD (P < 0.05). | URI: | https://hdl.handle.net/20.500.14279/9306 | ISSN: | 1945239X | DOI: | 10.1093/chromsci/bmv190 | Rights: | © Oxford University Press | Type: | Article | Affiliation: | Hellenic Anticancer Institute National and Kapodistrian University of Athens Cyprus University of Technology |
Εμφανίζεται στις συλλογές: | Άρθρα/Articles |
Αρχεία σε αυτό το τεκμήριο:
Αρχείο | Περιγραφή | Μέγεθος | Μορφότυπος | |
---|---|---|---|---|
Christophi.pdf | 512.78 kB | Adobe PDF | Δείτε/ Ανοίξτε |
CORE Recommender
SCOPUSTM
Citations
4
checked on 14 Μαρ 2024
WEB OF SCIENCETM
Citations
3
Last Week
0
0
Last month
0
0
checked on 29 Οκτ 2023
Page view(s)
385
Last Week
2
2
Last month
9
9
checked on 17 Μαϊ 2024
Download(s) 20
100
checked on 17 Μαϊ 2024
Google ScholarTM
Check
Altmetric
Όλα τα τεκμήρια του δικτυακού τόπου προστατεύονται από πνευματικά δικαιώματα